143 related articles for article (PubMed ID: 36722951)
41. Improved Detection of Postoperative Residual Meningioma with [
Bashir A; Larsen VA; Ziebell M; Fugleholm K; Law I
Clin Cancer Res; 2021 Apr; 27(8):2216-2225. PubMed ID: 33526423
[TBL] [Abstract][Full Text] [Related]
42. (68)Ga-DOTATATE-positron emission tomography imaging in spinal meningioma.
Slotty PJ; Behrendt FF; Langen KJ; Cornelius JF
J Craniovertebr Junction Spine; 2014 Jan; 5(1):44-6. PubMed ID: 25013347
[TBL] [Abstract][Full Text] [Related]
43. Analysis the causes of radiosurgical failure in intracranial meningiomas treated with radiosurgery.
Kim M; Cho YH; Kim JH; Kim CJ; Kwon DH
Clin Neurol Neurosurg; 2017 Mar; 154():51-58. PubMed ID: 28129632
[TBL] [Abstract][Full Text] [Related]
44. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
45. Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PET.
Stetter I; Werner JM; Schroeter M; Baumann C; Neuneier J; Schlamann M; Schmidt M; Drzezga A; Fink GR; Galldiks N
Clin Nucl Med; 2023 May; 48(5):e235-e236. PubMed ID: 36758554
[TBL] [Abstract][Full Text] [Related]
46. Detection of Metastatic Meningioma to the Liver Using 68Ga-DOTA-Octreotate PET/CT.
Villanueva-Meyer JE; Magill ST; Lee JC; Umetsu SE; Flavell RR
Clin Nucl Med; 2018 Sep; 43(9):e338-e340. PubMed ID: 29939957
[TBL] [Abstract][Full Text] [Related]
47. Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma.
Müther M; Roll W; Brokinkel B; Zinnhardt B; Sporns PB; Seifert R; Schäfers M; Weckesser M; Stegger L; Stummer W; Rahbar K
Nuklearmedizin; 2020 Sep; 59(5):348-355. PubMed ID: 32691404
[TBL] [Abstract][Full Text] [Related]
48. Somatostatin receptor-positive granulomatous inflammation mimicking as meningioma on simultaneous PET/MRI.
Taneja S; Jena A; Kaul S; Jha A; Sogani SK
Clin Nucl Med; 2015 Jan; 40(1):e71-2. PubMed ID: 24662657
[TBL] [Abstract][Full Text] [Related]
49. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery.
Liu RS; Chang CP; Guo WY; Pan DH; Ho DM; Chang CW; Yang BH; Wu LC; Yeh SH
J Nucl Med; 2010 Jun; 51(6):883-91. PubMed ID: 20484430
[TBL] [Abstract][Full Text] [Related]
50. Dynamic
Ivanidze J; Roytman M; Skafida M; Kim S; Glynn S; Osborne JR; Pannullo SC; Nehmeh S; Ramakrishna R; Schwartz TH; Knisely JPS; Lin E; Karakatsanis NA
Radiol Imaging Cancer; 2022 Mar; 4(2):e210067. PubMed ID: 35275019
[TBL] [Abstract][Full Text] [Related]
51. Multimodal treatment of parasagittal meningiomas: a single-center experience.
Gatterbauer B; Gevsek S; Höftberger R; Lütgendorf-Caucig C; Ertl A; Mallouhi A; Kitz K; Knosp E; Frischer JM
J Neurosurg; 2017 Dec; 127(6):1249-1256. PubMed ID: 28156245
[TBL] [Abstract][Full Text] [Related]
52. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
[TBL] [Abstract][Full Text] [Related]
53. Benefits of combined use of
Peciu-Florianu I; Jaillard A; Tuleasca C; Reyns N
J Med Case Rep; 2023 Jul; 17(1):300. PubMed ID: 37452350
[TBL] [Abstract][Full Text] [Related]
54. 68 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
Hartmann K; Gillman JA; Lazor JW; Ware JB; Weeks JK; Nasrallah IM; Farwell MD; Pantel AR
Clin Nucl Med; 2024 Jan; 49(1):9-15. PubMed ID: 38048554
[TBL] [Abstract][Full Text] [Related]
55. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
[TBL] [Abstract][Full Text] [Related]
56. Radiotherapy for atypical meningiomas.
Mair R; Morris K; Scott I; Carroll TA
J Neurosurg; 2011 Oct; 115(4):811-9. PubMed ID: 21699480
[TBL] [Abstract][Full Text] [Related]
57. Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications.
Roytman M; Pisapia DJ; Liechty B; Lin E; Skafida M; Magge RS; Osborne JR; Pannullo SC; Knisely JPS; Ramakrishna R; Ivanidze J
Clin Imaging; 2020 Oct; 66():18-22. PubMed ID: 32442855
[TBL] [Abstract][Full Text] [Related]
58. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
[TBL] [Abstract][Full Text] [Related]
59. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
[TBL] [Abstract][Full Text] [Related]
60. Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT.
Unterrainer M; Ilhan H; Vettermann F; Cyran CC; Tonn JC; Niyazi M; Bartenstein P; Albert NL
Clin Nucl Med; 2019 Mar; 44(3):227-228. PubMed ID: 30589668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
